TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
If You Invested $100 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today - TransMedics Group ( NASDAQ:TMDX )
TransMedics Group ( NASDAQ: TMDX ) has outperformed the market over the past 5 years by 37.76% on an annualized basis producing an average annual return of 52.39%. Currently, TransMedics Group has a market capitalization of $3.89 billion.
Here's Why TransMedics ( TMDX ) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why TransMedics ( TMDX ) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today - TransMedics Group ( NASDAQ:TMDX )
TransMedics Group TMDX has outperformed the market over the past 5 years by 33.81% on an annualized basis producing an average annual return of 48.66%. Currently, TransMedics Group has a market capitalization of $3.90 billion.
Why TransMedics ( TMDX ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
$100 Invested In TransMedics Group 5 Years Ago Would Be Worth This Much Today - TransMedics Group ( NASDAQ:TMDX )
TransMedics Group TMDX has outperformed the market over the past 5 years by 32.45% on an annualized basis producing an average annual return of 45.27%. Currently, TransMedics Group has a market capitalization of $4.00 billion.
Why Is TransMedics ( TMDX ) Down 1.9% Since Last Earnings Report?
TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Investigation Alert: Elanco Animal Health Incorporated, Driven Brands Holdings, Hasbro, and TransMedics: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors - Elanco Animal Health ( NYSE:ELAN ) , Driven Brands Hldgs ( NASDAQ:DRVN )
SAN DIEGO, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of the following companies: Elanco Animal Health Incorporated ELAN, Driven Brands Holdings Inc. DRVN, Hasbro, Inc.
Here's Why TransMedics ( TMDX ) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why TransMedics ( TMDX ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics
Insider moves in IonQ, Hims and Hers, Eli Lilly, and TransMedics reveal bold buys, record sales, and signals worth watching.
3 Unusual Insider Transactions you Should Know About
While no single indicator can guarantee a stock's performance, the pattern of insider transactions can provide a powerful glimpse into a company's prospects.
TransMedics ( TMDX ) Recently Broke Out Above the 50-Day Moving Average
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
Spotlight on TransMedics Group: Analyzing the Surge in Options Activity - TransMedics Group ( NASDAQ:TMDX )
Financial giants have made a conspicuous bearish move on TransMedics Group. Our analysis of options history for TransMedics Group TMDX revealed 18 unusual trades. Delving into the details, we found 38% of traders were bullish, while 44% showed bearish tendencies.
RadNet Posts Better-Than-Expected Earnings, Joins Tegna, MeridianLink, Lithium Argentina And Other Big Stocks Moving Higher On Monday - BitMine Immersion Techs ( AMEX:BMNR ) , Albemarle ( NYSE:ALB )
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Monday. Shares of RadNet, Inc. RDNT rose sharply during Monday's session after the company reported better-than-expected second-quarter financial results.
Why TransMedics ( TMDX ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why TransMedics ( TMDX ) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) - TransMedics Group ( NASDAQ:TMDX )
ANDOVER, Mass., Aug. 1, 2025 /PRNewswire/ -- TransMedics Group, Inc. ( "TransMedics" ) TMDX, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on July 28, 2025, TransMedics granted ...
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
TransMedics stock jumps 10.5% as Q2 EPS beats by 91.7%, revenue rises 37.7%, and operating margin expands 1230 basis points.
What TransMedics Just Taught Me About Trusting The Algorithm - TransMedics Group ( NASDAQ:TMDX )
Back in Robin Cook's 1977 novel Coma-and Michael Crichton's 1978 film adaptation-healthy patients are deliberately pushed into irreversible comas so their organs can be harvested and sold on the black market.
Why TransMedics Stock Is Skyrocketing Today
TransMedics continues to lock in its status as the leader in organ transplant technology.
TransMedics ( TMDX ) Q2 Revenue Jumps 38%
TransMedics Group ( NASDAQ:TMDX ) , a leader in organ transplant technology, released its second quarter 2025 earnings on July 30, 2025. The company topped Wall Street expectations, posting GAAP revenue of $157.4 million, ahead of the $147.7 million analyst estimate, and delivering GAAP earnings ...
TransMedics Group Stock Jumps On Q2 Earnings Beat, Company Raises 2025 Outlook - TransMedics Group ( NASDAQ:TMDX )
TransMedics reports second-quarter revenue of $157.37 million, beating estimates of $146.74 million. TransMedics reports second-quarter earnings of 92 cents per share, beating analyst estimates of 44 cents per share. Get special access to three exclusive "Top 10 Stocks" power lists today, ...
TransMedics ( TMDX ) Q2 Earnings and Revenues Surpass Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +91.67% and +6.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TransMedics Sees Its Earnings Soar
TransMedics reported second-quarter financial results that were considerably better than most investors had anticipated. Investors were also pleased that TransMedics increased its guidance for the full 2025 year.
Countdown to TransMedics ( TMDX ) Q2 Earnings: Wall Street Forecasts for Key Metrics
Beyond analysts' top-and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Organ Preservation Market is expected to generate a revenue of USD 414.24 Million by 2032, Globally, at 6.65% CAGR: Verified Market Research®
Lewes, Delaware, July 28, 2025 ( GLOBE NEWSWIRE ) -- The Global Organ Preservation Market Size is projected to grow at a CAGR of 6.65% from 2026 to 2032, according to a new report published by Verified Market Research®.
Veracyte ( VCYT ) Soars 7.0%: Is Further Upside Left in the Stock?
Veracyte (VCYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Price Over Earnings Overview: TransMedics Group - TransMedics Group ( NASDAQ:TMDX )
In the current session, TransMedics Group Inc. TMDX is trading at $103.90, after a 5.44% drop. Over the past month, the stock fell by 21.67%, and in the past year, by 33.13%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ...
Top 3 Health Care Stocks That Could Blast Off In July - RxSight ( NASDAQ:RXST ) , Sarepta Therapeutics ( NASDAQ:SRPT )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge - Federal Agricultural ( NYSE:AGM ) , MiNK Therapeutics ( NASDAQ:INKT )
U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones index dipping more than 250 points on Friday. The Dow traded down 0.60% to 44,382.58 while the NASDAQ rose 0.06% to 20,643.06. The S&P 500 also fell, dropping, 0.23% to 6,266.23. In trading on Friday, health care ...
Is TransMedics Stock a Buy After Short-Seller Drama?
Explore the exciting world of TransMedics ( NASDAQ: TMDX ) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!*Stock prices used were the prices of May 28, 2025.
Investigation Alert: The Estée Lauder Companies, Driven Brands Holdings, Hasbro, and TransMedics: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors - Driven Brands Hldgs ( NASDAQ:DRVN ) , Estee Lauder Cos ( NYSE:EL )
SAN DIEGO, July 03, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of the following companies: The Estée Lauder Companies Inc. EL, Driven Brands Holdings Inc. DRVN, Hasbro, Inc. HAS, and TransMedics Group, ...
2 Stocks That Have Doubled This Year and Are Still Worth Buying
Positive, company-specific developments have led to shares of TransMedics Group ( NASDAQ: TMDX ) and FuboTV ( NYSE: FUBO ) more than doubling this year, even as the S&P 500 is barely in the green since January. Investing wisdom advises us to buy low, and some might think that after a greater than ...
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global ...
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
Price Over Earnings Overview: TransMedics Group - TransMedics Group ( NASDAQ:TMDX )
In the current market session, TransMedics Group Inc. TMDX share price is at $142.88, after a 0.12% drop. Over the past month, the stock spiked by 17.52%, but over the past year, it actually fell by 0.14%.
Kuehn Law Encourages Investors of TransMedics Group, Inc. to Contact Law Firm - TransMedics Group ( NASDAQ:TMDX )
NEW YORK, June 10, 2025 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of TransMedics Group, Inc. TMDX breached their fiduciary duties to shareholders.
TransMedics ( TMDX ) Just Flashed Golden Cross Signal: Do You Buy?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
Earnings Estimates Moving Higher for TransMedics ( TMDX ) : Time to Buy?
TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes TransMedics ( TMDX ) a New Buy Stock
TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years
While being an innovative company doesn't guarantee superior long-term returns, it doesn't hurt those chances either. In fact, when a corporation is making important breakthroughs and boasts significant growth prospects in its industry, that could translate to above-average stock market ...
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?
Shares of TransMedics Group ( NASDAQ: TMDX ) recently bounded higher in response to a first-quarter earnings report that was a lot better than investors were expecting. Downward revenue guidance revisions and unwanted attention from short-sellers pushed the stock down late last year, but things ...
Investor Alert: Wolfspeed, Driven Brands Holdings, Hasbro, and TransMedics: Johnson Fistel, PLLP Investigates Claims on Behalf of Investors - Driven Brands Hldgs ( NASDAQ:DRVN ) , Hasbro ( NASDAQ:HAS )
SAN DIEGO, May 09, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential violations of federal and state laws by certain officers of the following companies: Wolfspeed, Inc. WOLF, Driven Brands Holdings Inc. DRVN, Hasbro, Inc. HAS, and TransMedics Group, Inc. TMDX.
Why TransMedics Stock Is Skyrocketing Today
Shares of next-generation transplant technology platform TransMedics ( NASDAQ: TMDX ) were up 21% as of noon ET on Friday, according to data provided by S&P Global Market Intelligence.TransMedics reported first-quarter results that saw revenue balloon 48% and the company's net income margin rise ...
TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down
Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.
Insulet Posts Upbeat Earnings, Joins Trade Desk, TransMedics Group, Tesla And Other Big Stocks Moving Higher On Friday - Definitive Healthcare ( NASDAQ:DH ) , AvePoint ( NASDAQ:AVPT )
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Friday. Shares of Insulet Corporation PODD rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance above estimates.
